The Portable Medical Ventilators Market is segmented by modality, with non-invasive ventilation (NIV) holding the largest share. NIV delivers respiratory support through a mask or other interface without the need for an invasive artificial airway, such as an endotracheal tube. It is widely used for conditions like sleep apnea, COPD, and acute respiratory failure. NIV is preferred over invasive ventilation when appropriate because it is associated with fewer complications, such as ventilator-associated pneumonia, and allows patients to remain more comfortable and mobile. The growth of NIV is driven by the increasing prevalence of conditions that can be managed with this modality and the development of more comfortable and effective masks and devices.

While NIV dominates, invasive ventilation remains an essential segment for patients who cannot be adequately supported with non-invasive methods. Invasive ventilation requires the placement of an endotracheal tube or tracheostomy and is typically used in intensive care settings or for patients with severe respiratory failure. However, portable invasive ventilators are also used in home care for patients with conditions such as spinal cord injury or neuromuscular disease who require long-term mechanical ventilation. Advances in portable invasive ventilators have made them smaller, quieter, and more reliable, enabling patients to be managed outside the hospital.

The choice between NIV and invasive ventilation depends on the patient's clinical condition, the cause of respiratory failure, and the anticipated duration of support. The development of devices that can provide both non-invasive and invasive ventilation in a single platform is a growing trend, offering flexibility as the patient's condition evolves. The continued innovation in both modalities will drive market growth and improve patient outcomes.